US Stock MarketDetailed Quotes

Xilio Therapeutics (XLO)

Watchlist
  • 8.360
  • -0.450-5.11%
Close May 15 16:00 ET
  • 8.360
  • 0.0000.00%
Post 19:39 ET
50.02MMarket Cap-3.67P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics (XLO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
331.67%12.65M
589.88%43.77M
693.85%13.69M
742.51%19.07M
242.98%8.08M
2.93M
6.34M
1.72M
2.26M
2.36M
Operating revenue
331.67%12.65M
589.88%43.77M
693.85%13.69M
742.51%19.07M
242.98%8.08M
--2.93M
--6.34M
--1.72M
--2.26M
--2.36M
Cost of revenue
Gross profit
Operating expense
59.47%26.76M
29.94%85.75M
66.23%25.52M
23.02%21M
31.82%22.45M
1.46%16.78M
-16.61%65.99M
-15.32%15.35M
-1.70%17.07M
-15.34%17.03M
Selling and administrative expenses
-18.64%6.93M
19.90%29.71M
13.55%7.4M
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
-General and administrative expense
-18.64%6.93M
19.90%29.71M
13.55%7.4M
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
Research and development costs
139.92%19.83M
35.98%56.04M
105.09%18.12M
33.11%14.32M
36.68%15.33M
-20.52%8.27M
-20.95%41.21M
-24.71%8.84M
-2.64%10.76M
-15.15%11.22M
Operating profit
-1.88%-14.11M
29.61%-41.98M
13.16%-11.84M
86.97%-1.93M
2.10%-14.37M
16.25%-13.85M
24.63%-59.65M
24.83%-13.63M
14.73%-14.8M
27.05%-14.67M
Net non-operating interest income expense
Other net income (expense)
682.08%4.58M
394.73%6.95M
4,041.04%22.2M
-1,933.72%-14.36M
-297.33%-1.48M
188.25%586K
-48.55%1.4M
12.84%536K
27.73%783K
-1.58%749K
Gain on sale of security
--3.3M
--5.85M
--21.28M
---15.38M
---50K
----
----
----
----
----
Special income (charges)
----
--0
--0
--0
--0
--0
---937K
--0
--41K
---30K
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
--0
--937K
--0
---41K
--30K
Other non- operating income (expenses)
118.94%1.28M
-52.97%1.1M
71.83%921K
37.74%1.02M
-283.31%-1.43M
106.34%586K
-14.22%2.34M
12.84%536K
21.04%742K
2.37%779K
Income before tax
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Income tax
Net income
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Net income continuous Operations
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Minority interest income
Net income attributable to the parent company
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Basic earnings per share
76.71%-0.58
72.51%-4.19
134.29%0.96
50.00%-1.54
33.33%-2.24
71.31%-2.49
60.84%-15.24
68.75%-2.8
63.93%-3.08
65.71%-3.36
Diluted earnings per share
76.71%-0.58
72.51%-4.19
128.93%0.81
50.00%-1.54
33.33%-2.24
71.31%-2.49
60.84%-15.24
68.75%-2.8
63.93%-3.08
65.71%-3.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 331.67%12.65M589.88%43.77M693.85%13.69M742.51%19.07M242.98%8.08M2.93M6.34M1.72M2.26M2.36M
Operating revenue 331.67%12.65M589.88%43.77M693.85%13.69M742.51%19.07M242.98%8.08M--2.93M--6.34M--1.72M--2.26M--2.36M
Cost of revenue
Gross profit
Operating expense 59.47%26.76M29.94%85.75M66.23%25.52M23.02%21M31.82%22.45M1.46%16.78M-16.61%65.99M-15.32%15.35M-1.70%17.07M-15.34%17.03M
Selling and administrative expenses -18.64%6.93M19.90%29.71M13.55%7.4M5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M
-General and administrative expense -18.64%6.93M19.90%29.71M13.55%7.4M5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M
Research and development costs 139.92%19.83M35.98%56.04M105.09%18.12M33.11%14.32M36.68%15.33M-20.52%8.27M-20.95%41.21M-24.71%8.84M-2.64%10.76M-15.15%11.22M
Operating profit -1.88%-14.11M29.61%-41.98M13.16%-11.84M86.97%-1.93M2.10%-14.37M16.25%-13.85M24.63%-59.65M24.83%-13.63M14.73%-14.8M27.05%-14.67M
Net non-operating interest income expense
Other net income (expense) 682.08%4.58M394.73%6.95M4,041.04%22.2M-1,933.72%-14.36M-297.33%-1.48M188.25%586K-48.55%1.4M12.84%536K27.73%783K-1.58%749K
Gain on sale of security --3.3M--5.85M--21.28M---15.38M---50K--------------------
Special income (charges) ------0--0--0--0--0---937K--0--41K---30K
-Less：Restructuring and merger&acquisition ------0--0--0--0--0--937K--0---41K--30K
Other non- operating income (expenses) 118.94%1.28M-52.97%1.1M71.83%921K37.74%1.02M-283.31%-1.43M106.34%586K-14.22%2.34M12.84%536K21.04%742K2.37%779K
Income before tax 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Income tax
Net income 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Net income continuous Operations 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Minority interest income
Net income attributable to the parent company 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Basic earnings per share 76.71%-0.5872.51%-4.19134.29%0.9650.00%-1.5433.33%-2.2471.31%-2.4960.84%-15.2468.75%-2.863.93%-3.0865.71%-3.36
Diluted earnings per share 76.71%-0.5872.51%-4.19128.93%0.8150.00%-1.5433.33%-2.2471.31%-2.4960.84%-15.2468.75%-2.863.93%-3.0865.71%-3.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -